Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

Buy-and-Bill

COVID-19

Case-Based Roundtable

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Editorial Advisory Board

Partners

Subscribe

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Articles

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.

Dermatology Times 2024 In Review: Vitiligo

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Deucravacitinib achieved ACR20 response in patients with PsA at week 16, with a safety profile consistent with previous studies.

Phase 3 Trials Confirm Deucravacitinib’s Efficacy in PsA 

Dermatology Times is looking back on the top dermatology news headlines from 2024.

Derm In The News: 2024

Kaitlyn Bader is the assistant managing editor of 

 and joined the MJH Life Sciences team in June 2022. She attended Otterbein University in Westerville, Ohio, and earned a Bachelor of Arts degree in literary studies with minors in creative writing and film studies. Prior to health care news, Kaitlyn worked in industrial marketing. She enjoys cooking, reading, and tending to her house plants.

At the inaugural Horizons in Advanced Practice meeting, Dr. Noor highlighted the value of amplifying the voices of physician assistants and nurse practitioners to advance patient care. 

Empowering PAs and NPs: Omar Noor, MD, Reflects on Horizons in Advanced Practice Meeting 

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

1rem

Journal

Innovative Perspectives: Aesthetic Authority Vol. 2: No. 3

Smart Skin Care: Aesthetic Authority Vol. 2: No. 2

Technology Pipeline: Aesthetic Authority Vol. 2: No. 1 

Looking Forward: Aesthetic Authority Vol.1: No.4

Balancing Act: Aesthetic Authority Vol.1: No.3

Every aspect of our personal and professional lives has been affected in some way by the onset of COVID-19. 

As we work towards structuring new normalcies, we understand the importance of continuing to pursue the work we are passionate about. For us, that’s researching and sharing the latest innovations and insights within the aesthetic specialty. For our physicians, it’s practicing aesthetic medicine safely and doing so with confidence.

, we bring you cutting-edge treatment- and trend-related content, while also confronting some of the real issues affecting the specialty. We take a serious look at diversity in aesthetics as well as pandemic-related legal issues and lessons learned from the COVID-19 shutdown. This issue features several physicians who are finding ways to creatively navigate this largely uncharted territory in which we find ourselves. Dr. Suneel Chilukuri shares a new “functional” use for the body toning technologies. Others share new opportunities in skincare sales and addressing the rise in stress-induced hair loss. In one of the first virtual meetings that took place since the onset of the pandemic, Dr. Kian Karimi suggests that threads are the new “injectable,” and Dr. Jacob Haiavyshares his protocols for managing or treating capsular contracture with LED light.

We hope you glean clinical and practice insights from this issue, and embrace hope during the current challenges, as elucidated by our Medical Editorial Advisor Dr. Randolph Waldman in his editorial, “‘Here Comes the Sun.’”

Uncharted Territory: Aesthetic Authority Vol.1: No.2

The Toxin Pipeline: Aesthetic Authority Vol.1: No.1